Good morning. It’s Friday, September 6th. Hahnemann Hospital will be allowed to sell its medical-residency program to Thomas Jefferson University Hospitals for $55 million. And the federal government has seven days to appeal the decision by a U.S. bankruptcy judge. The proposed sale was being challenged by federal regulators that claimed the deal was illegal. The ruling marks a key turning point in Hahnemann’s bankruptcy filing, providing much-needed funds to begin paying off creditors.